Literature DB >> 32715804

ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids.

Zahra Soleimani1,2, Azam Soleimani3.   

Abstract

BACKGROUND: Management of acute respiratory distress syndrome (ARDS) in pregnant women infected with new severe acute respiratory syndrome Corona virus 2 (SARS-CoV2) is a challenging clinical task. CASE: A 30- year-old woman (gravid 3, parity 2) presented at her 21 and 2/7 weeks gestation (pre pregnancy BMI: 36.1 kg/m2), with ARDS caused by SARS-CoV2 infection. She received lopinavir/ritonavir and azithromycin as well as early methyl prednisolone therapy. Given the persistent hypoxemia despite oxygen therapy via non rebreather face mask (FiO2:80%), convalescent plasma transfusion was administered that led to a mild clinical improvement as well as decrease in inflammatory markers. Growth of her fetus assessed by obstetric sonography was normal during hospital stay.
CONCLUSION: Judicious corticosteroid therapy along with convalescent plasma transfusion to suppress viremia and cytokine storm can lead to favorable outcome in the pregnant women with ARDS caused by SARS-CoV2 infection without superimposed bacterial infection.

Entities:  

Keywords:  Pregnancy; SARS-CoV2; acute respiratory distress syndrome; convalescent plasma transfusion; corticosteroid

Mesh:

Substances:

Year:  2020        PMID: 32715804     DOI: 10.1080/14767058.2020.1797669

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  7 in total

1.  Two-dimensional reciprocal cross entropy multi-threshold combined with improved firefly algorithm for lung parenchyma segmentation of COVID-19 CT image.

Authors:  Guowei Wang; Shuli Guo; Lina Han; Anil Baris Cekderi
Journal:  Biomed Signal Process Control       Date:  2022-06-22       Impact factor: 5.076

2.  Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors:  Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal:  JMIR Public Health Surveill       Date:  2021-04-07

3.  Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

Authors:  Vanessa Piechotta; Claire Iannizzi; Khai Li Chai; Sarah J Valk; Catherine Kimber; Elena Dorando; Ina Monsef; Erica M Wood; Abigail A Lamikanra; David J Roberts; Zoe McQuilten; Cynthia So-Osman; Lise J Estcourt; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2021-05-20

4.  Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis.

Authors:  Pallavi Dubey; Bhaskar Thakur; Sireesha Reddy; Carla A Martinez; Md Nurunnabi; Sharron L Manuel; Sadhana Chheda; Christina Bracamontes; Alok K Dwivedi
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-24       Impact factor: 3.007

5.  The use of convalescent plasma therapy in the management of a pregnant woman with COVID-19: a case report.

Authors:  Lígia Walter Moura; Adolfo Wenjaw Liao; Romulo Negrini; Eduardo Zlotnik
Journal:  Einstein (Sao Paulo)       Date:  2022-02-16

Review 6.  COVID-19 Disease During Pregnancy and Peripartum Period: A Cardiovascular Review.

Authors:  Sedigheh Hantoushzadeh; Seyedeh Maedeh Nabavian; Zahra Soleimani; Azam Soleimani
Journal:  Curr Probl Cardiol       Date:  2021-05-09       Impact factor: 5.200

Review 7.  Presentation and Outcome of Congenital Heart Disease During Covid-19 Pandemic: A Review.

Authors:  Azam Soleimani; Zahra Soleimani
Journal:  Curr Probl Cardiol       Date:  2021-05-29       Impact factor: 5.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.